Jane Street
LXRX icon

Jane Street’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jane Street’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6K Buy
+14,500
New +$21.1K ﹤0.01% 11174
2025
Q4 		– Sell
-11,300
Closed -$15.3K – 11862
2025
Q3 		$15.3K Buy
+11,300
New +$12.8K ﹤0.01% 10560
2024
Q3 		– Sell
-19,100
Closed -$32.1K – 10077
2024
Q2 		$32.1K Hold
19,100
– – ﹤0.01% 8995
2024
Q1 		$45.8K Buy
+19,100
New +$41K ﹤0.01% 8755
2023
Q3 		– Sell
-76,000
Closed -$174K – 9064
2023
Q2 		$174K Buy
+76,000
New +$202K ﹤0.01% 7738
2021
Q3 		– Sell
-20,700
Closed -$95K – 10392
2021
Q2 		$95K Buy
+20,700
New +$99.7K ﹤0.01% 9288

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's LXRX Position: Q1 2026 in Review

Jane Street increased its Lexicon Pharmaceuticals (LXRX) stake by 55% in Q1 2026, buying an estimated $1.37M and bringing the position to 2,665,938 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

Jane Street first reported a position in LXRX in Q3 2013 and has held it in 25 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Jane Street held 2,665,938 shares of Lexicon Pharmaceuticals worth $4.16M as of Q1 2026.
  • Jane Street bought 941,634 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $1.37M.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3778 holding.
  • Jane Street first reported a position in Lexicon Pharmaceuticals in Q3 2013 and has held it in 25 quarters since.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.